SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
---|---|---|---|---|---|---|---|---|
26-Apr-17 8:17 PM View: | Audentes Therapeutics, Inc. (BOLD) | 24-Apr-17 | Market Purchase | 172,413 | $14.50 | $2,499,990.00 | 7% 2.39M to 2.56M | 71% |
25-Jul-16 5:06 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Conversion | 2,322,130 | -- | -- | 100% 0 to 2.32M | |
25-Jul-16 5:06 PM View: | Audentes Therapeutics, Inc. (BOLD) | 25-Jul-16 | Purchase | 70,000 | $15.00 | $1,050,000.00 | 3% 2.32M to 2.39M | |
06-Feb-15 3:48 PM View: | Epirus Biopharmaceuticals, ... (ZLCS) | 04-Feb-15 | Purchase Duplicate | 400,000 | $5.00 | $2,000,000.00 | 18% 2.21M to 2.61M | |
11-Dec-14 4:55 PM View: | Relypsa Inc (RLYP) | 09-Dec-14 | Market Sale | 589,637 | $30.04 | $17,712,700.00 | (24%) 2.48M to 1.89M | (6%) |
20-Nov-13 7:13 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Conversion | 1,558,200 | -- | -- | 100% 0 to 1.56M | |
20-Nov-13 7:13 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Payment of Exercise | 8,731 | $11.00 | $96,041.00 | (< 1%) 2.49M to 2.48M | |
20-Nov-13 7:13 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Option Exercise | 558,220 | $0.17 | $94,897.40 | 36% 1.56M to 2.12M | |
20-Nov-13 7:13 PM View: | Relypsa Inc (RLYP) | 20-Nov-13 | Purchase | 372,692 | $11.00 | $4,099,610.00 | 18% 2.12M to 2.49M |